joint pain on retatrutide Arthritis and Pain: Symptoms and Treatment Options TRIUMPH-4: Retatrutide Delivers Weight Loss,

What Was Approved

In another study involving more than 96,000 patients initiating GLP-1s, 46% of patients with and 65% without Type 2 diabetes discontinued the drugs within one year

This is the key distinction

Metformins therapeutic efficacy in the treatment of diabetes does not involve inhibition of mitochondrial glycerol phosphate dehydrogenase

In patients treated with GLP-1RAs and tirzepatide, gastrointestinal side effects such as nausea and vomiting are common but do not significantly contribute to weight loss

GLP-1 medications are considered pregnancy category C, which means their safety during pregnancy has not been firmly established